Unbiased AI-powered news
9 stories related to this topic, newest first.
Washington ExaminerGermany is preparing new rules that would reduce payments for innovative medicines. The change comes as other European countries have agreed to higher prices in recent trade talks. Officials in the United States have linked the issue to broader trade negotiations with the Europea…
Washington ExaminerThe proposal would link U.S. prescription drug prices to the lowest prices paid by foreign governments. A patient advocate argues the approach could reduce funding for pharmaceutical research and limit patient access to new medicines.
The GuardianAustralia's government introduced the News Bargaining Incentive to shield publishers from big tech's use of news content. President Trump imposed a 100% tariff on imported pharmaceuticals, but Australia stated it would not raise drug prices. On International Day of the Midwife, g…
upi.comThe Trump Administration secured voluntary most-favored-nation pricing agreements with 17 of the world's largest pharmaceutical manufacturers. The policy aligns US drug prices with lower rates in other developed countries and projects savings for Medicare beneficiaries.
rediff.comA recent poll indicates that a majority of registered voters support several key policies of President Trump, such as deporting violent criminal illegal immigrants and reducing prescription drug prices. Support levels ranged from 63% to 84% for specific measures, according to the…
Biotech company Regeneron has entered into an agreement with the U.S. government to reduce medication costs for American patients. The deal includes offering a new hearing-loss gene therapy at no charge to eligible individuals. This is part of broader efforts to align U.S. drug p…
Substrate placeholder — needs reviewChina's State Council has released new guidelines aimed at supporting innovative drug pricing through value-based methods while reducing generic drug prices via market competition. A Citigroup analyst described the guidelines as the most significant in a decade.
Substrate placeholder — needs reviewA recent Senate report indicates that 15 of 16 drugmakers involved in a Trump administration initiative have increased prescription drug prices since early 2025. The report also questions the effectiveness of the TrumpRx online platform in providing savings to patients.
medpagetoday.comThe FDA will hold an advisory panel meeting to consider allowing compounding pharmacies to produce certain peptides. A recent review of Alzheimer’s drugs found limited clinical benefits, though some experts noted differences among the drugs studied. Additionally, a report indicat…